UNIGE document Scientific Article
previous document  unige:48430  next document
add to browser collection
Title

Pédiatrie Vaccin conjugué contre les pneumocoques : quel bilan quatre ans après son introduction ?

Authors
Published in Revue médicale suisse. 2005, vol. 1, no. 2, p. 142,144,146-7
Abstract Considerable morbidity and mortality are related to pneumococcal disease predominantly in high risk populations: infants and young children, the elderly and the immunocompromised. A recent heptavalent conjugate anti-pneumococcal vaccine, introduced in the routine immunization program in the United States in 2001, has been shown to be spectacularly effective in the prevention of invasive disease in the very young in contrast to the pre-existing polysaccharide vaccine. As a consequence, horizontal transmission throughout the community is decreased with a reduction in disease rates in non-vaccinated adults. Finally the conjugate vaccine also provides an effective tool for reduction of drug-resistant pneumococcal strains. A review of the existing anti-pneumococcal vaccines, their direct and indirect effects and their recommended use in Switzerland.
Keywords Child, PreschoolHumansInfantMeningococcal VaccinesPneumococcal Infections/prevention & controlPneumococcal VaccinesTime FactorsVaccines, Conjugate
Identifiers
PMID: 15773216
Full text
Structures
Research groups Centre de Vaccinologie et d'Immunologie néonatale (177)
Etiologie des pneumonies et marqueurs inflammatoires chez l'enfant fébrile (183)
Citation
(ISO format)
MYERS, Catherine Jayne, GERVAIX, Alain. Pédiatrie Vaccin conjugué contre les pneumocoques : quel bilan quatre ans après son introduction ?. In: Revue médicale suisse, 2005, vol. 1, n° 2, p. 142,144,146-7. https://archive-ouverte.unige.ch/unige:48430

134 hits

1 download

Update

Deposited on : 2015-03-25

Export document
Format :
Citation style :